Michelle Holko, PhD, PMP, is a scientist and strategic innovator working at the intersection of biology, technology, and security. She recently served in government as a White House Presidential Innovation Fellow (PIF) and led projects with NIH, DHS CISA, HHS BARDA and DOD Chem Bio Defense. Her technical expertise is in genomics, bioinformatics, biosecurity, and wearable sensor data; she has experience in academia and in government working on solutions for cancer, pandemic preparedness and prevention, data stewardship, digital health technology, health equity, and security related to new and emerging technology in health and science. She was most recently a Strategic Business Executive and Scientist at Google Public Sector for healthcare and science. She also is a PI leading research at the intersection between cybersecurity and biotechnology / life sciences research at the International Computer Science Institute (ICSI) at Berkeley.

Jackie is the senior analyst leading the biorisk team to rapidly report, assess and forecast outbreaks globally. She previously graduated from Imperial College London with an MSc in Genomic Medicine, where she investigated the safety and efficacy of COVID-19 treatments on patients with underlying cardiovascular risk factors and had her dissertation published. She also holds a BSc in animal biology from the University of British Columbia.

Dr. Cunningham-Hill is an employee health expert known for his ability to create, identify and implement high-quality workplace health programs including prevention and screening, chronic illness interventions, and mental health and wellbeing initiatives. His broad occupational medicine and public health experience encompasses addressing chronic diseases impacting employers, employees and communities within the context of  social, cultural and racial determinants of health.

Mark has served as the Medical Director for Northeast Business Group on Health since early 2018. Until 2017, he served as Senior Director, Global Solutions Center and Head of Occupational Medicine at Johnson & Johnson, Inc . At J&J, Mark led a team of experts covering occupational medicine, health and wellness, personal energy management, EAP and mental wellbeing, and work-life effectiveness, and supported regional operational groups delivering health services to 135,000 employees in 120 companies. Prior to seven years at J&J, Mark spent 17 years at GlaxoSmithKline in both London and Philadelphia, including as Head of Global Operations, Employee Health Management.

Mark received his MB ChB, Bachelor of Medicine and Bachelor of Surgery at Manchester University in the UK. He is a Fellow of both the American College of Occupational & Environmental Medicine, and the Faculty of Occupational Medicine, London.